BioCentury
ARTICLE | Clinical News

Corplex Donepezil Transdermal System: Phase I data

February 15, 2016 8:00 AM UTC

Top-line data from an open-label, crossover, Australian Phase I trial in 9 healthy volunteers ages 50-80 showed that the Corplex Donepezil Transdermal System targeted to deliver 5 mg/day of donepezil ...